Assignee
CYTOGEL PHARMA LLC
US·8 granted patents·14 pending applications·9 citations·filing 2011–2024
Top patents by PatentIndex Score
22 records- 0186US8940704B2Advantageous salts of μ-opiate receptor peptidesCYTOGEL PHARMA LLC·Filed 2013·Granted Jan 27, 2015·6 cites·7 claims
- 0283US11324798B2Materials and methods for treatment of inflammationCYTOGEL PHARMA LLC·Filed 2020·Granted May 10, 2022·1 cites·1 claims
- 0380US10975121B2Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereofCYTOGEL PHARMA LLC·Filed 2018·Granted Apr 13, 2021·1 cites·1 claims
- 0479US2023212221A1Novel Therapeutic Uses of Mu-Opiate Receptor PeptidesCYTOGEL PHARMA LLC·Filed 2022·Application pending·0 cites
- 0578US2025074941A1Polymer Agonists of Mu Opioid ReceptorsCYTOGEL PHARMA LLC·Filed 2024·Application pending·0 cites
- 0677US2022324908A1Advantageous salts of mu-opiate receptor peptidesCYTOGEL PHARMA LLC·Filed 2021·Application pending·0 cites
- 0775US12146002B2Polymer agonists of mu opioid receptorsCYTOGEL PHARMA LLC·Filed 2022·Granted Nov 19, 2024·0 cites·13 claims
- 0875US10441625B2Materials and methods for treatment of inflammationCYTOGEL PHARMA LLC·Filed 2018·Granted Oct 15, 2019·1 cites·2 claims
- 0974US2022249593A1Materials and Methods for Treatment of InflammationCYTOGEL PHARMA LLC·Filed 2022·Application pending·0 cites
- 1071US2020339628A1Advantageous salts of mu-opiate receptor peptidesCYTOGEL PHARMA LLC·Filed 2020·Application pending·0 cites
- 1171US2021277057A1Advantageous mu-opiate receptor peptide compoundsCYTOGEL PHARMA LLC·Filed 2021·Application pending·0 cites
- 1268US2020331962A1Novel therapeutic uses of mu-opiate receptor peptidesCYTOGEL PHARMA LLC·Filed 2020·Application pending·0 cites
- 1365US2015152137A1Advantageous salts of mu-opiate receptor peptidesCYTOGEL PHARMA LLC·Filed 2014·Application pending·0 cites
- 1464US11603385B2Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereofCYTOGEL PHARMA LLC·Filed 2020·Granted Mar 14, 2023·0 cites·4 claims
- 1564US2018291060A1Advantageous salts of mu-opiate receptor peptidesCYTOGEL PHARMA LLC·Filed 2018·Application pending·0 cites
- 1663US12037416B2Polymer agonists of mu opioid receptorsCYTOGEL PHARMA LLC·Filed 2018·Granted Jul 16, 2024·0 cites·10 claims
- 1762US2019307831A1Materials and methods for treatment of inflammationCYTOGEL PHARMA LLC·Filed 2019·Application pending·0 cites
- 1859US2018282370A1Novel therapeutic uses of mu-opiate receptor peptidesCYTOGEL PHARMA LLC·Filed 2018·Application pending·0 cites
- 1959US2018251490A1Advantageous mu-opiate receptor peptide compoundsCYTOGEL PHARMA LLC·Filed 2018·Application pending·0 cites
- 2058US2015126455A1Novel Therapeutic Uses of Mu-Opiate Receptor PeptidesCYTOGEL PHARMA LLC·Filed 2013·Application pending·0 cites
- 2154US2016264625A1Advantageous mu-opiate receptor peptide compoundsCYTOGEL PHARMA LLC·Filed 2016·Application pending·0 cites
- 2247US8034383B2Injectable microspheresCYTOGEL PHARMA LLC·Filed 2011·Granted Oct 11, 2011·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when CYTOGEL PHARMA LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →